Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of PDGFRB Mutations With Pediatric Myofibroma and Myofibromatosis

24 Apr 2019

Abstract excerpt

IMPORTANCE: Myofibroma is the most frequent fibrous tumor in children. Multicentric myofibroma (referred to as infantile myofibromatosis) is a life-threatening disease. OBJECTIVE: To determine the frequency, spectrum, and clinical implications of mutations in the PDGFRB receptor tyrosine kinase found in sporadic myofibroma and myofibromatosis. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective study of 69...

Topics

Join the communities discussing this publication.

Musculoskeletal synovial abnormalities and treatments
Sarcoma Diagnosis and Treatment
Soft tissue tumor case studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31017643
DOI: 10.1001/jamadermatol.2019.0114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of PDGFRB Mutations With Pediatric Myofibroma and MyofibromatosisPMID 31017643Read ↗

PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.Semantic proximity Read ↗

Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapySemantic proximity Read ↗

Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working GroupSemantic proximity Read ↗

High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot PDGFRB Mutations.Semantic proximity Read ↗

Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB geneSemantic proximity Read ↗

PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.Semantic proximity Read ↗

Modulation of expressivity in PDGFRB-related infantile myofibromatosis: a role for PTPRG?Semantic proximity Read ↗

[Sporadic infantile myofibromatosis: Mutations with PDGFRB gain-of-function].Semantic proximity Read ↗

A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib.Semantic proximity Read ↗

Heterozygous PDGFRB Mutation in a Three-generation Family with Autosomal Dominant Infantile Myofibromatosis.Semantic proximity Read ↗

Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and MyopericytomasSemantic proximity Read ↗

Novel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.